The stock of Oak Street Health Inc. (NYSE:OSH) increased by increased by $0.47 on Friday to finish at $46.92, up 1.01 percent. The last five days have seen an average of 1,134,140 shares of common stock traded. 3 times new highs were reached in the current year, with a fall of -$14.24. The average number of shares traded over the last 20 days was 1,521,950, while the average volume over the last 50 days totaled 1,658,552.
OSH stock dropped -3.79% since last month. On 10/12/21, the company’s shares reached a one-month low of $35.67. The stock touched a high of $66.31 on 02/12/21, after rallying from a low of $35.67 in 52 weeks. The price of OSH stock has declined by -23.28% or -$14.24 this year, reaching a new high 3 times. Still, the stock price is down -29.24% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
There have been 4 days since Oak Street Health Inc. (OSH) last reported insider trading activity on Oct 21. On Oct 21, Chief Legal Officer GUENTHNER ROBERT sold 10,328 shares at $45.75 each. This transaction resulted in the insider making $472,505. On Oct 19, PYKOSZ MICHAEL T sold 50,000 shares at a price of US$41.82. After the transaction, the insider now owns 7,467,240 shares. Chief Medical Officer MYERS GRIFFIN had earlier sold 109,400 shares on Oct 15 for $41.65 a share. The transaction was completed for $4,556,215.
For the three months ended June 29, Oak Street Health Inc.’s quick ratio was 3.40, while its current ratio was 3.40, indicating its ability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 5.70% percent. Oak Street Health Inc.’s EBITDA margin for the year ended June 29 was -20.43%, whereas its operating margin stood at -27.70% for the same period. Based on annual data, it had gross profit of $77.41 million and revenue of $882.76 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. OSH’s return on assets (ROA) during the last 12 months has been -25.10%. There was a -44.10% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -91.60%. ROE has averaged 9.65 in the past year for the broader industry.
According to Oak Street Health Inc.’s quarterly financial report for the quarter that ended June 29, it had $669.2 million in cash and short-term investments. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $353.1 million, while revenues rose by 39.29% to $296.7 million. It was predicted that Oak Street Health Inc.’s quarterly earnings would be -$0.44, but it ended up being -$0.34, beating the consensus by -29.40%. EBITDA was -$93.9 million for the quarter. At the end of Oak Street Health Inc.’s most recent quarter ended June 29, its liabilities totaled 1.51 billion, while its total debt was $1.05 billion. Equity owned by shareholders amounts to $240.86 million.
Here’s a quick look at Oak Street Health Inc.’s (OSH) price momentum from a technical perspective. As of 22 October, the RSI 9-day stood at 68.30%, suggesting the stock is Neutral, with a 31.75% historical volatility rate.
The stochastic %K and %D were 96.73% and 85.06% respectively, while the average true range (ATR) was 2.03. Based on the 14-day stochastic reading of 97.32%, the RSI (14) reading is 58.72%. On the 9-day MACD Oscillator, the stock is at 3.52, and the 14-day reading is at 4.57.
In its analyst report released on October 20, 2021, Jefferies began covering Oak Street Health Inc. (NYSE: OSH). The stock was rated as a Buy by the brokerage firm. Analysts have assigned Oak Street Health Inc. (OSH) an Buy rating. OSH is a stock that is recommended for selling by 0 brokerage firms, while 2 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 3 rates it overweight and 14 others recommend it as a buy.
What is OSH’s price target for the next 12 months?
The current consensus forecast for the stock is between $50.00 and $76.00, with a median target price of $61.00. In analyzing these forecasts, the average price target given by analysts for Oak Street Health Inc. (OSH) is $62.88.